Pound foolish and penny wise-when will dosing of rifampicin be optimised?

Cecile Magis-Escurra; Richard M. Anthony; Adri G. M. van der Zanden; Dick van Soolingen; Jan-Willem C. Alffenaar

doi:10.1016/S2213-2600(18)30044-4

Pound foolish and penny wise-when will dosing of rifampicin be optimised?

Cecile Magis-Escurra^*
, Richard M. Anthony
, Adri G. M. van der Zanden
, Dick van Soolingen
, Jan-Willem C. Alffenaar

^*Corresponding author for this work

Microbes in Health and Disease (MHD)

Research output: Contribution to journal › Letter (Research letter) › Academic › peer-review

12 Citations (Scopus)

47 Downloads (Pure)

Original language	English
Pages (from-to)	E11-E12
Number of pages	2
Journal	The Lancet. Respiratory Medicine
Volume	6
Issue number	4
DOIs	https://doi.org/10.1016/S2213-2600(18)30044-4
Publication status	Published - Apr-2018

Keywords

TUBERCULOUS MENINGITIS
INTENSIFIED REGIMEN
MOXIFLOXACIN
TRIAL
RESISTANCE

Access to Document

10.1016/S2213-2600(18)30044-4

Pound foolish and penny wiseFinal publisher's version, 164 KBLicence: Taverne

Handle.net

Persistent link

Cite this

@article{b9461fa4e9e646d6abe533b2cdf0c248,

title = "Pound foolish and penny wise-when will dosing of rifampicin be optimised?",

keywords = "TUBERCULOUS MENINGITIS, INTENSIFIED REGIMEN, MOXIFLOXACIN, TRIAL, RESISTANCE",

author = "Cecile Magis-Escurra and Anthony, \{Richard M.\} and \{van der Zanden\}, \{Adri G. M.\} and \{van Soolingen\}, Dick and Alffenaar, \{Jan-Willem C.\}",

year = "2018",

month = apr,

doi = "10.1016/S2213-2600(18)30044-4",

language = "English",

volume = "6",

pages = "E11--E12",

journal = "The Lancet. Respiratory Medicine",

issn = "2213-2600",